Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
562.3 BRL | +7.02% | +3.75% | +20.49% |
Sales 2024 * | 171B 897B | Sales 2025 * | 182B 954B | Capitalization | 125B 655B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B 42.12B | Net income 2025 * | 9.09B 47.57B | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 17.34B 90.76B | Net Debt 2025 * | 13.7B 71.71B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
13.6
x | Employees | 104,900 |
Yield 2024 * |
1.17% | Yield 2025 * |
1.27% | Free-Float | 99.6% |
Latest transcript on Elevance Health, Inc.
1 day | +7.02% | ||
1 week | +3.75% | ||
1 month | +4.43% | ||
3 months | +12.69% | ||
6 months | +21.27% | ||
Current year | +20.49% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 562.3 | +7.02% | 83 |
24-05-29 | 525.4 | -1.22% | 2 |
24-05-28 | 531.9 | -1.87% | 3 |
Delayed Quote Sao Paulo, May 31, 2024 at 03:48 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.91% | 456B | |
+15.08% | 97.9B | |
-21.78% | 43.15B | |
-3.53% | 38.2B | |
-27.51% | 2.57B | |
-8.59% | 1.51B | |
+15.53% | 546M |
- Stock Market
- Equities
- ELV Stock
- E1LV34 Stock